ACP & Stem Cell Therapies for Pain Management is organized by Empire Medical Training (EMT), Inc and will be held on Sep 27, 2019 at Sheraton Orlando Lake Buena Vista Resort, Orlando, Florida, United States of America.
Target Audience:
This activity has been designed to meet the educational needs of Health Care Practitioners involved in the care of the patients with Aesthetic requests.
Accreditation:
Physician Credit
Medical Education Resources designates this live activity, for a maximum of 6.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit
Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This CE activity provides 6.25 contact hours of continuing nursing education.
Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for [6.25] contact hours.
Description:
Autologous Conditioned Plasma (ACP) aka PRP has numerous corrective pain management indications for patients that are non-responsive to conventional treatments. ACP injections have been utilized with a number of medical conditions including tendinopothies, joint pain, arthritis, and sports medicine applications. In this 1-Day course, you will receive extensive training in the harvesting and administration of ACP including the use of biologics (concentrated growth factors) such as amniotic tissue as well as stem cells derived from adipose cells for use in patients. Enhance patient care and realize the benefits of using and offering these regenerative therapies within your practice and create new revenue streams and greater patient satisfaction.
This evidence-based course will prepare attendees to diagnose, harvest, and administer these regenerative therapies in an office setting. These interventional procedures can be performed safely within an office setting (clean procedure | aseptic procedure) and can be used in combination with conventional treatments without complications and to the benefits of patients. Autologous Conditioned Plasma (PRP) can be used as a stand-alone treatment effectively or combined with Allograft CGF (Concentrated Growth Factors) to compliment traditional pain management therapies. Typically, ACP injections are cash basis procedures and the average cost to patients is approximately $600 – $800 per injection cycle (before biologics) or treatment in pain management applications.
Program Overview:
The ACP & Stem Cell Therapies for Interventional Pain Management seminar is a combination lecture and workshop where learners will participate in didactic lectures in the morning followed by hands on training in the afternoon. Learners will understand how to utilize the latest therapies in relation to ACP, Amniotic Derivative Products, BMAC, ASC, and Umbilical Cord Blood (UCB). The purpose of the training is to help learners provide enhanced patient care to those who present themselves with various medical and pain management conditions. Target audience includes healthcare professionals for procedures which have not been taught in their previous medical education.
Learning Outcome:
To provide learners with a foundation for following correct standards of care and acquire the necessary technical skills to perform each of these procedures correctly and by adhering to published protocols and guidelines
Educational Objectives:
- Practice procedures such as ACP (Platelet Rich Plasma) and Amnio Products (Stem Cells) competently, safely, and effectively for their patient. Each participant will understand and learn how to avoid risks and associated complications.
- Apply generally accepted protocols for the administration of Platelet Rich Plasma for various chronic and sub-acute medical conditions.
- Describe the mechanism of action of Platelet Rich Plasma and the Amnio products available and differences between the product characteristics, patient preferences, managing expectations, and after care for follow up after the interventional pain injection procedures.
- Identify who is a candidate for Platelet Rich Plasma (ACP) Therapies and the use of the additive Amniotic derived products available, patient benefits, and long-term expectations and additional treatments dependent upon patient presentation. Increase patient awareness and offer enhanced patient care in relation to this non-invasive, non-surgical procedure.
Registration Desk
| Contact No. : | 866-366-1576 |
| Email: |
